About the Authors

Anna Rydén

anna.ryden@astrazeneca.com

Affiliation AstraZeneca, Mölndal, Sweden

Elisabeth Sörstadius

Affiliation AstraZeneca, Mölndal, Sweden

Klas Bergenheim

Affiliation AstraZeneca, Mölndal, Sweden

Alexandru Romanovschi

Affiliation AstraZeneca, Mississauga, Canada

Fredrik Thorén

Affiliation AstraZeneca, Mölndal, Sweden

Edward A. Witt

Affiliation Kantar Health, Princeton, NJ, United States of America

Catarina Sternhufvud

Affiliation AstraZeneca, Mölndal, Sweden

Competing Interests

The authors received funding from AstraZeneca, a commercial company, for this study, both in funding and in salary. Author EW received funding from Kantar Health, a commercial company, in the form of salary. Kantar Health was paid for EW’s consultation on this study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: A. Rydén ES KB A. Romanovschi FT EW CS. Formal analysis: EW. Methodology: A. Rydén ES KB A. Romanovschi FT EW CS. Writing – original draft: A. Rydén EW. Writing – review & editing: A.Rydén ES KB A. Romanovschi FT EW CS.